Hopp til hovedinnhold

Bronkiolitt, akutt, rs-virus

Akutt bronkiolitt kan starte som en forkjølelse. Barnet kan være medtatt, hoster og har gjerne pipende eller hvesende tung pust. Hyppigst er tilstanden forårsaket av RS-virus.

Sist oppdatert: Sist revidert:


Hva er akutt bronkiolitt ?

Hva er RS-virus ?

Diagnosen

Behandling

Barnehage/dagmamma

Forebygging

Prognosen

Vil du vite mer?

Kilder

Referanser

Dette dokumentet er basert på det profesjonelle dokumentet Bronkiolitt. Referanselisten for dette dokumentet vises nedenfor.

  1. Meissner HC. Viral Bronchiolitis in Children. New England Journal of Medicine. 2016;374(1):62–72. www.nejm.org 
  2. Skjerven HO, Øymar K, Hunderi JO, Nag T. Akutt bronkiolitt i Akuttveileder i pediatri. Revidert 2019. Siden lest 04.05.2022 www.helsebiblioteket.no 
  3. Piedra PA. Bronchiolitis in infants and children: Clinical features and diagnosis. UpToDate. Topic last uppdated Mar 09, 2020. www.uptodate.com 
  4. Smith DK, Seales S, Budzik C. Respiratory syncytial virus bronchiolitis in children. Am Fam Physician 2017; 95: 94-99. American Family Physician 
  5. Zorc JJ, Hall CB. Bronchiolitis: Recent Evidence on Diagnosis and Management. Pediatrics 2010; 125: 342-49. Pediatrics 
  6. Haskell L, Tavender EJ, Wilson CL, et al. Effectiveness of Targeted Interventions on Treatment of Infants With Bronchiolitis A Randomized Clinical Trial. JAMA Pediatr 2021. pmid:33843971 PubMed 
  7. Nielsen LM, Halgrener J, Lühr Hansen BV. Respiratorisk syncytialvirus-infektioner hos børn i almen praksis. Ugeskr Læger 2003; 165: 2747-9. PubMed 
  8. Risnes KR, Radke A, Nordbø SA, Grammeltvedt AT, Døllner H. Humant metapneumovirus - forekomst og klinisk betydning. Tidsskr Nor Lægeforen 2005; 125: 2769-72. PubMed 
  9. CDC. Human Metapneumovirus (HMPV). Clinical Features. Sist oppdatert 2017. Siden besøkt 16.04.2018 www.cdc.gov 
  10. Ralston SL, Lieberthal AS, Meissner HC, et al. Clinical practice guideline: The diagnosis, management, and prevention of bronchiolitis. Pediatrics 2014. doi.10.1542/peds.2014-2742
  11. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-128. pmid:23245604 PubMed 
  12. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289: 179. pmid:12517228 PubMed 
  13. Hashem M, Hall CB. Respiratory syncytial virus in healthy adults: the cost of a cold. J Clin Virol 2003; 27: 14-21. PubMed 
  14. Kulkarni H, Smith CM, Lee Ddo H, et al. Evidence of respiratory syncytial virus spread by aerosol: Time to revisit infection control strategies? Am J Respir Crit Care Med 2016; 194: 308-16. PMID: 26890617 PubMed 
  15. Gadomski AM, Scribani MB. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2014;6. DOI: 10.1002/14651858.CD001266.pub4. The Cochrane Library 
  16. Norsk barnelegeforening. Gjør kloke valg. Siden besøkt 26.02.2021. www.legeforeningen.no 
  17. Florin TA, Plint AC, Zorc JJ. Viral bronchiolitis. Lancet. 2017; 389: 211-224. PMID: 27549684 PubMed 
  18. Skjerven HO, Hunderi JO, Brügmann-Pieper SK, et al. Racemic adrenaline and inhalation strategies in acute bronchiolitis. N Engl J Med 2013; 368: 2286-93. doi:10.1056/NEJMoa1301839 DOI 
  19. Cunningham S, Rodriguez A, Adams T, et al. Oxygen saturation targets in infants with bronchiolitis (BIDS): a double-blind, randomised, equivalence trial. Lancet. 2015; 386 :1041-8. doi: 10.1016/S0140-6736(15)00163-4. DOI 
  20. Jat KR, Mathew JL. Continuous positive airway pressure (CPAP) for acute bronchiolitis in children. Cochrane Database of Systematic Reviews 2015, Issue 1. Art. No.: CD010473. DOI: 10.1002/14651858.CD010473.pub2 DOI 
  21. Mahant S, Parkin PC, Thavam T, et al. Rates in Bronchiolitis Hospitalization, Intensive Care Unit Use, Mortality, and Costs From 2004 to 2018. JAMA Pediatr 2022; 176: 270-279. PMID: 34928313 PubMed 
  22. Brunet J, Gill PJ, Imsirovic H, et al. Evaluation of Bronchiolitis-Related Emergency Department Visits From 2004 to 2018 A Population-Based Cohort Study. JAMA Pediatr 2022. pmid:35499845 PubMed 
  23. McLellan JS, Chen M, Joyce MG, et al. Structure-based design of afusion glycoprotein vaccine for respiratory syncytial virus. Science 2013; 342: 592-8. doi:10.1126/science.1243283 DOI 
  24. Garegnani L, Styrmisdottir L, Roson Rodriguez P, et al. Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children. Cochrane Database Syst Rev. 2021 Nov 16;11:CD013757. doi: 10.1002/14651858.CD013757.pub2. DOI 
  25. Farber HJ, Buckwold FJ, Lachman B, et al. Observed effectiveness of palivizumab for 29–36-week gestation infants. Pediatrics 2016. PMID: 27432850 PubMed 
  26. Hammitt LL, Dagan R, Yuan Y, et al. Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants. N Engl J Med 2022; 386: 837-846. pmid:35235726 PubMed 
  27. Black CP. Systematic review of the biology and medical management of respiratory syncytial virus infection. Respir Care 2003; 48: 209-31. PubMed 
  28. Zorc JJ, Hall CB. Bronchiolitis: REcent evidence on diagnosis and management. Pediatrics 2010; 125: 342. Pediatrics 
  29. Brannsether Ellingsen B, Amdal Aase S, Øymar K. Forebygging av respiratorisk syncytialvirus-infeksjoner med palivizumab. Tidsskr Nor Lægeforen 2003; 123: 941-3. PubMed 
  30. Skjerven HO, Rolfsjord LB, Berents TL, et al. Allergic diseases and the effect of inhaled epinephrine in children with acute bronchiolitis: follow-up from the randomised, controlled, double-blind, Bronchiolitis ALL trial. Lancet Resp Med 2015; 3: 702-8. doi:10.1016/S2213-2600(15)00319-7 DOI